iOnctura is developing next generation, best-in-class molecules with dual therapeutic potential in cancer and fibrotic indications.

FIND OUT MORE GET IN TOUCH

Our Pipeline

We are developing a pipeline of carefully selected assets. Programs in oncology aim to harness both immune-mediated and direct anti-tumour activity to deliver superior clinical efficacy in monotherapy or combinations. By building on complementary mechanisms between cancer and fibrosis iOnctura further aims to address high unmet need in fibrotic disease.

our current projects

Pipeline

WHO WE ARE

MEET THE TEAM

HOW WE'RE FIGHTING CANCER

iOnctura is developing next generation, best-in-class molecules with dual therapeutic potential in cancer and fibrotic indications.

MORE
Cancer Research UK Merck Dutch Cancer Institute
LATEST NEWS

By building on complementary mechanisms between cancer and fibrosis iOnctura further aims to address high unmet need in fibrotic disease.

GET IN TOUCH